Ignacio Anegon
Ignacio Anegon is a co-founder of AbolerIS Pharma and is based in France. He co-founded the company in November 2019 and was a senior consultant there until November 2024.
Since May 1988 he has been a Director of Research Exceptional at INSERM Institut national de la santé et de la recherche médicale, where he directed the INSERM-CRTI Center from 2009 to 2018 and was scientific director of the Transgenesis Rat ImmunoPhenomic facility from 1999 to 2022. He led a team at INSERM unit 1064-CRTI from June 1989 until November 2022, and directed Labex IGO from 2016 to 2020.
At the Federation of Clinical Immunology Societies (FOCIS) he directed the FOCIS Center of Excellence of Nantes University from 2005 to 2022, chaired the International FOCIS Centers of Excellence from 2016 to 2022 and the Education Committee from 2020 to 2022. He has been Vice-President since June 2022 and holds the presidency for the term from June 2024 to June 2026.
He studied medicine at the Universidad de la República from 1975 to 1982 and took a Habilitatio à Diriger des Recherches in biology at Nantes Université, completed in 1998.
Career
- Federation of Clinical Immunology Societies (FOCIS)Vice-President FOCISJun 2022 – Present
- INSERM Institut national de la santé et de la recherche médicaleDirector of Research Exceptional (DRE) at INSERMMay 1988 – Present
- Federation of Clinical Immunology Societies (FOCIS)Président FOCISJun 2024 – Jun 2026
- Federation of Clinical Immunology Societies (FOCIS)Chairman Education Committee of FOCISJun 2020 – Apr 2022
AbolerIS PharmaCo-Founder and Senior Consultant of AbolerIS Pharma (http://aboleris-pharma.com/)Nov 2019 – Nov 2024
- Federation of Clinical Immunology Societies (FOCIS)Chairman International FOCIS Centers of ExcellenceJun 2016 – Nov 2022
- Labex IGODirector Labex Immunolgy Graft OncologyJan 2016 – Jan 2020
- InsermDirector of INSERM-CRTI CenterJan 2009 – Jan 2018
- Federation of Clinical Immunology Societies (FOCIS)Director Focis Center of Excellence of Nantes UniversityJan 2005 – Apr 2022
- InsermScientific Director Transgenesis Rat ImmunoPhenomic (TRIP) facilityJan 1999 – Apr 2022
- INSERM unit 1064-CRTITeam leader at INSERM-CRTIJun 1989 – Nov 2022
- Nantes Université#243schoolHabilitatio à Diriger des Recherches, Biologie1996 - 1998
- Universidad de la RepúblicaDoctor of Medicine - MD1975 - 1982
- escuela Benito Juarez
From public career histories · 14 entries